Istvan Vincze

Budapest, BU 1089, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Assays for Monitoring Apixaban and Rivaroxaban in Emergency Settings, State-of-the-Art Routine Analysis, and Volumetric Absorptive Microsamples Deliver Discordant Results.

Assays for Monitoring Apixaban and Rivaroxaban in Emergency Settings, State-of-the-Art Routine Analysis, and Volumetric Absorptive Microsamples Deliver Discordant Results.

Journal: Diagnostics (Basel, Switzerland)

Published: July 07, 2024

Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin.

Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin.

Journal: Pharmaceutics

Published: September 28, 2023

Therapeutic Monitoring of Orally Administered, Small-Molecule Anticancer Medications with Tumor-Specific Cellular Protein Targets in Peripheral Fluid Spaces-A Review.

Therapeutic Monitoring of Orally Administered, Small-Molecule Anticancer Medications with Tumor-Specific Cellular Protein Targets in Peripheral Fluid Spaces-A Review.

Journal: Pharmaceutics

Published: November 11, 2022

Assessment of Antibiotic Pharmacokinetics, Molecular Biomarkers and Clinical Status in Critically Ill Adults Diagnosed with Community-Acquired Pneumonia and Receiving Intravenous Piperacillin/Tazobactam and Hydrocortisone over the First Five Days of Intensive Care: An Observational Study (STROBE Compliant).

Assessment of Antibiotic Pharmacokinetics, Molecular Biomarkers and Clinical Status in Critically Ill Adults Diagnosed with Community-Acquired Pneumonia and Receiving Intravenous Piperacillin/Tazobactam and Hydrocortisone over the First Five Days of Intensive Care: An Observational Study (STROBE Compliant).

Journal: Journal of clinical medicine

Published: June 08, 2022

A High-Throughput Clinical Laboratory Methodology for the Therapeutic Monitoring of Ibrutinib and Dihydrodiol Ibrutinib.

A High-Throughput Clinical Laboratory Methodology for the Therapeutic Monitoring of Ibrutinib and Dihydrodiol Ibrutinib.

Journal: Molecules (Basel, Switzerland)

Published: May 27, 2022

A pharmacokinetics-based approach to the monitoring of patient adherence to atorvastatin therapy.

A pharmacokinetics-based approach to the monitoring of patient adherence to atorvastatin therapy.

Journal: Pharmacology research & perspectives

Published: July 26, 2021

Sensitive, High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Analysis of Atorvastatin and Its Pharmacologically Active Metabolites in Serum for Supporting Precision Pharmacotherapy.

Sensitive, High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Analysis of Atorvastatin and Its Pharmacologically Active Metabolites in Serum for Supporting Precision Pharmacotherapy.

Journal: Molecules (Basel, Switzerland)

Published: January 30, 2021

The Impact of Differentiation on Cytotoxicity and Insulin Sensitivity in Streptozotocin Treated SH-SY5Y Cells.

The Impact of Differentiation on Cytotoxicity and Insulin Sensitivity in Streptozotocin Treated SH-SY5Y Cells.

Journal: Neurochemical research

Published: November 22, 2020

Analysis of 14 drugs in dried blood microsamples in a single workflow using whole blood and serum calibrators.

Analysis of 14 drugs in dried blood microsamples in a single workflow using whole blood and serum calibrators.

Journal: Bioanalysis

Published: September 11, 2020

The effect of L-theanine and S-ketamine on d-serine cellular uptake.

The effect of L-theanine and S-ketamine on d-serine cellular uptake.

Journal: Biochimica et biophysica acta. Proteins and proteomics

Published: February 28, 2020

Characterization of a Cell Line Model for d-Serine Uptake.

Characterization of a Cell Line Model for d-Serine Uptake.

Journal: Journal of pharmaceutical and biomedical analysis

Published: January 31, 2020

Development of a methodology to make individual estimates of the precision of liquid chromatography-tandem mass spectrometry drug assay results for use in population pharmacokinetic modeling and the optimization of dosage regimens.

Development of a methodology to make individual estimates of the precision of liquid chromatography-tandem mass spectrometry drug assay results for use in population pharmacokinetic modeling and the optimization of dosage regimens.

Journal: PloS one

Published: October 15, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026